Papers
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7400.1167 (Published 29 May 2003) Cite this as: BMJ 2003;326:1167Related articles
- Editor's Choice Published: 29 May 2003; BMJ 326 doi:10.1136/bmj.326.7400.0-g
- This Week In The BMJ Published: 29 May 2003; BMJ 326 doi:10.1136/bmj.326.7400.0
- Review Published: 29 May 2003; BMJ 326 doi:10.1136/bmj.326.7400.1220-a
- Head To Head Published: 30 November 2009; BMJ 339 doi:10.1136/bmj.b4949
- Research Published: 04 May 2006; BMJ 332 doi:10.1136/bmj.38768.420139.80
- RESEARCH Published: 17 March 2006; BMJ doi:10.1136/bmj.38768.420139.80
- Research Published: 06 December 2007; BMJ 335 doi:10.1136/bmj.39385.413113.25
- RESEARCH Published: 16 November 2007; BMJ doi:10.1136/bmj.39385.413113.25
- RESEARCH Published: 16 January 2006; BMJ doi:10.1136/bmj.38693.516782.7C
- News Published: 26 January 2006; BMJ 332 doi:10.1136/bmj.38693.516782.7C
- Views & Reviews Published: 04 February 2009; BMJ 338 doi:10.1136/bmj.b439
- Paper Published: 01 December 2005; BMJ 331 doi:10.1136/bmj.38628.561123.7C
- PAPERS Published: 18 November 2005; BMJ doi:10.1136/bmj.38628.561123.7C
- RESEARCH Published: 22 February 2006; BMJ doi:10.1136/bmj.38737.607558.80
- Research Published: 23 March 2006; BMJ 332 doi:10.1136/bmj.38737.607558.80
- Research Methods & Reporting Published: 24 March 2010; BMJ 340 doi:10.1136/bmj.c332
- Research Published: 12 October 2006; BMJ 333 doi:10.1136/bmj.38973.444699.0B
- RESEARCH Published: 06 October 2006; BMJ doi:10.1136/bmj.38973.444699.0B
- Research Published: 06 December 2007; BMJ 335 doi:10.1136/bmj.39376.447211.BE
- RESEARCH Published: 16 November 2007; BMJ doi:10.1136/bmj.39376.447211.BE
- Head To Head Published: 30 November 2009; BMJ 339 doi:10.1136/bmj.b4953
- Observations Published: 19 November 2008; BMJ 337 doi:10.1136/bmj.a2535
- Research Published: 19 March 2010; BMJ 340 doi:10.1136/bmj.c1344
- Editorial Published: 23 February 2006; BMJ 332 doi:10.1136/bmj.332.7539.437
- Research Published: 28 March 2011; BMJ 342 doi:10.1136/bmj.d1569
- Observations Published: 25 May 2011; BMJ 342 doi:10.1136/bmj.d3004
- Research Published: 11 October 2011; BMJ 343 doi:10.1136/bmj.d5621
- Observations Published: 15 February 2012; BMJ 344 doi:10.1136/bmj.e1075
- Observations Published: 08 May 2012; BMJ 344 doi:10.1136/bmj.e3247
- Editorial Published: 14 June 2012; BMJ 344 doi:10.1136/bmj.e3952
- Research Published: 20 August 2012; BMJ 345 doi:10.1136/bmj.e5155
- Research Methods & Reporting Published: 09 January 2013; BMJ 346 doi:10.1136/bmj.e7586
- Editorial Published: 29 April 2014; BMJ 348 doi:10.1136/bmj.g2750
- Letter Published: 24 April 2012; BMJ 344 doi:10.1136/bmj.e2927
- Research Methods & Reporting Published: 21 July 2009; BMJ 339 doi:10.1136/bmj.b2700
- Paper Published: 29 September 2005; BMJ 331 doi:10.1136/bmj.331.7519.742
- Editor's Choice Published: 01 December 2005; BMJ 331 doi:10.1136/bmj.331.7528.0-f
- Feature Published: 03 May 2007; BMJ 334 doi:10.1136/bmj.39185.394005.AD
- Editorial Published: 07 February 2008; BMJ 336 doi:10.1136/bmj.39409.633576.BE
- Research Methods & Reporting Published: 21 September 2017; BMJ 358 doi:10.1136/bmj.j4008
- Feature Published: 05 December 2018; BMJ 363 doi:10.1136/bmj.k5056
- Research Published: 06 November 2019; BMJ 367 doi:10.1136/bmj.l5896
- Research Published: 05 February 2020; BMJ 368 doi:10.1136/bmj.m7
- Analysis Published: 27 July 2021; BMJ 374 doi:10.1136/bmj.n1657
- Research Published: 01 February 2023; BMJ 380 doi:10.1136/bmj-2022-072415
- Analysis Published: 06 November 2023; BMJ 383 doi:10.1136/bmj-2023-076441
See more
- Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysisBMJ December 05, 2016, 355 i6188; DOI: https://doi.org/10.1136/bmj.i6188
- Alpha blockers for treatment of ureteric stones: systematic review and meta-analysisBMJ December 01, 2016, 355 i6112; DOI: https://doi.org/10.1136/bmj.i6112
- Sex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analysesBMJ November 24, 2016, 355 i5826; DOI: https://doi.org/10.1136/bmj.i5826
- Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysisBMJ November 23, 2016, 355 i5953; DOI: https://doi.org/10.1136/bmj.i5953
- Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysisBMJ November 07, 2016, 355 i5599; DOI: https://doi.org/10.1136/bmj.i5599
Cited by...
- Burden of proof: combating inaccurate citation in biomedical literature
- Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications
- Does industry funding and study location impact findings from randomized controlled trials of spinal cord stimulation? A systematic review and meta-analysis
- Interventions to improve migrants access to sexual and reproductive health services: a scoping review
- Systematic assessment of opioid advertisements in general medical journals
- Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews
- Effects of specialised nutritional interventions in patients with incurable cancer: a systematic review
- Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinsons in an international setting
- A cross-sectional examination of conflict-of-interest disclosures of physician-authors publishing in high-impact US medical journals
- Ten years later: a review of the US 2009 institute of medicine report on conflicts of interest and solutions for further reform
- Conflicted and confused? Health harming industries and research funding in leading UK universities
- Do we really know how many clinical trials are conducted ethically? Why research ethics committee review practices need to be strengthened and initial steps we could take to strengthen them
- Awareness and perceptions among members of a Japanese cancer patient advocacy group concerning the financial relationships between the pharmaceutical industry and physicians: a mixed-methods analysis of survey data
- Financial Conflicts of Interest of United States-Based Authors in Neurology Journals: Cross-Sectional Study Using the Open Payments Database
- Analysis of conflicts of interest among authors and researchers of European clinical guidelines in cardiovascular medicine
- Funding sources are under-reported in randomised clinical trials of biological treatments in sports medicine: a systematic review
- P-hacking in clinical trials and how incentives shape the distribution of results across phases*
- Using collaboration networks to identify authorship bias in meta-analyses
- Clinical Decision Support Systems for Opioid Prescribing for Chronic Non-Cancer Pain in Primary Care: A Scoping Review
- Article placement order in rheumatology journals: a content analysis
- P-hacking in clinical trials and how incentives shape the distribution of results across phases
- Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study
- Pitfalls and Safeguards in Industry-Funded Research
- Association between financial links to indoor tanning industry and conclusions of published studies on indoor tanning: systematic review
- Effect of revealing authors conflicts of interests in peer review: randomized controlled trial
- Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years
- Drop-out rates in placebo-controlled trials of antidepressant drugs: A systematic review and meta-analysis based on clinical study reports
- Scope and nature of financial conflicts of interest between neurologists and industry: 2013-2016
- Contextualising UK moorland burning studies: geographical versus potential sponsorship-bias effects on research conclusions
- Reporting animal research: Explanation and Elaboration for the ARRIVE guidelines 2019
- Action to protect the independence and integrity of global health research
- Assessing Confidence in the Results of Network Meta-Analysis (Cinema)
- Catalogue of bias: publication bias
- Overdiagnosis and industry influence: how cows milk protein allergy is extending the reach of infant formula manufacturers
- Top 20 POEMs of the Past 20 Years: A Survey of Practice-Changing Research for Family Physicians
- False Beliefs in Academic Psychiatry: The Case of Antidepressant Drugs
- Transparency on scientific instruments
- What data sources do ophthalmologists trust?
- Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance
- Lifeblood of a discipline
- Efficacy of individualised diets in patients with irritable bowel syndrome: a randomised controlled trial
- Comparison of veterinary drugs and veterinary homeopathy: part 2
- Patient safety during procedural sedation using capnography monitoring: a systematic review and meta-analysis
- Meta-assessment of bias in science
- Cost-effectiveness research in cancer therapy: a systematic review of literature trends, methods and the influence of funding
- Sponsorship bias in the comparative efficacy of psychotherapy and pharmacotherapy for adult depression: meta-analysis
- Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis
- Preparing Dental Students and Residents to Overcome Internal and External Barriers to Evidence-Based Practice
- All medicines have side effects
- Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology Meeting
- Bias in dissemination of clinical research findings: structured OPEN framework of what, who and why, based on literature review and expert consensus
- Statistical process control and interrupted time series: a golden opportunity for impact evaluation in quality improvement
- Basing approval of drugs for type 2 diabetes on real world outcomes
- From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology
- Creating and using real-world evidence to answer questions about clinical effectiveness
- Evening the score on sex drugs: feminist movement or marketing masquerade?
- Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statins
- Identifying Items to Assess Methodological Quality in Physical Therapy Trials: A Factor Analysis
- Trials of autologous bone marrow stem cells for heart disease
- The effect of funding sources on donepezil randomised controlled trial outcome: a meta-analysis
- Methodological characteristics and treatment effect sizes in oral health randomised controlled trials: Is there a relationship? Protocol for a meta-epidemiological study
- Do Cardiology Quality Measures Actually Improve Patient Outcomes?
- Conflicts of interest at the European Food Safety Authority erode public confidence
- Surrogacy of Financial Conflicts of Interest
- Financial Disclosure, Industry Sponsorship, and Integrity in Cancer Research Reporting
- Self-Reported Conflicts of Interest of Authors, Trial Sponsorship, and the Interpretation of Editorials and Related Phase III Trials in Oncology
- Authors' Self-Declared Financial Conflicts of Interest Do Not Impact the Results of Major Cardiovascular Trials
- SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
- Conflict of Interest Disclosure in Off-Label Oncology Clinical Trials
- Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study
- Widening the debate about conflict of interest: addressing relationships between journalists and the pharmaceutical industry
- New UK guidance on industry-health professional collaboration
- The dos and don'ts of collaborating with industry
- An alternative set of principles for consideration
- Financial Relationships in Economic Analyses of Targeted Therapies in Oncology
- Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals
- Assaulting alternative medicine: worthwhile or witch hunt?
- Intra-Articular Injection of Hyaluronic Acid Is Not Superior to Saline Solution Injection for Ankle Arthritis: A Randomized, Double-Blind, Placebo-Controlled Study
- Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study
- Industry and evidence-based medicine: Believable or conflicted? A systematic review of the surgical literature
- Rebuttal: Does family medicine have a professional obligation to play a leading role in pharmaceutical industry-sponsored drug research?: YES